C. Boulard

Calculation of cut‐off values based on the Autoimmune Bullous Skin Disorder Intensity Score ( <scp>ABSIS</scp> ) and Pemphigus Disease Area Index ( <scp>PDAI</scp> ) pemphigus scoring systems for defining moderate, significant and extensive types of pemphigus

C. Boulard, S. Duvert Lehembre, C. Picard‐Dahan et al. · British Journal of Dermatology · 2016 · 92 citations · Full text

Medicine, Dermatology, Autoimmunity +16

Most chilblains observed during the COVID‐19 outbreak occur in patients who are negative for COVID‐19 on polymerase chain reaction and serology testing*

Laurence Le Cleach, L. Dousset, H. Assier et al. · British Journal of Dermatology · 2020 · 80 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +14

Risk factors for treatment failure in scabies: a cohort study

Audrey Aussy, Estelle Houivet, V. Hébert et al. · British Journal of Dermatology · 2018 · 61 citations

Pharmacy, Pharmacotherapy, Allergy +12

Effectiveness and Safety of Anti-interleukin-17 Therapies in Elderly Patients with Psoriasis

C. Phan, N. Bénéton, J. Delaunay et al. · Acta Dermato Venereologica · 2020 · 35 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +16

Tattoo complications in treated and non‐treated psoriatic patients

C. Grodner, Alain Beauchet, Anne‐Claire Fougerousse et al. · Journal of the European Academy of Dermatology and Venereology · 2019 · 24 citations · Full text

Medicine, Dermatology, Allergy +8